Borealis Foods Discloses Nasdaq Audit Committee Deficiency and Board Reshuffle Tied to Related-Party Lender
BRLS sits 95% above its 52-week low of $0.6.
Summary
Borealis Foods disclosed that its audit committee fell to two members for about a month, curing it with a new director appointed by the lender that now holds its $17M term loan and $3M convertible note. That lender is the mother of a sitting director, making the debt a related-party arrangement.
Key Events · Corporate Governance and Compliance · BRLS
-
Audit Committee Fell Below Nasdaq Minimum
The audit committee had only two members from September 28, 2026 to October 29, 2026, breaching Nasdaq Listing Rule 5605(c)(2)(A)'s three-member requirement; the company notified Nasdaq on November 4, 2026 and believes compliance is restored.
-
Lender Now a Related Party
Oxus Capital assigned the $17,000,000 term loan and the $3,000,000 convertible note to Saule Algaziyeva effective July 31, 2026, with principal, interest, maturity and conversion terms unchanged and no novation. She is the mother of director Zaure Algaziyeva, so interest and principal payments are Item 404 related-party transactions.
-
Board and Committees Reshuffled
Pavel Mynzhanov resigned from the board on October 29, 2026, and Danat Shiderkulov was appointed the same day to the board and to the audit, compensation and nominating committees, which now consist of Steve Oyer (Chair), Amin Ajami and Shiderkulov.
-
Director Loses Independence Status
Zaure Algaziyeva resigned from all three committees on September 28, 2026 and the board determined on October 29, 2026 that she is no longer independent under Nasdaq rules because of her mother's lender role; she remains a director.
Analysis · BRLS · Manufacturing
The technical cure matters less than the reason behind it. Borealis briefly fell out of compliance with Nasdaq's three-member audit committee rule after Zaure Algaziyeva stepped off the committee on September 28, 2026, and only cured it on October 29, 2026 when Danat Shiderkulov joined the board and all three committees. Her mother, Saule Algaziyeva, took over the company's $17,000,000 term loan and $3,000,000 convertible note from Oxus Capital on July 31, 2026, making the lender a related party and stripping Zaure of her independence. Because the lender now nominates directors under the credit agreement, the board is being reshaped by the creditor rather than by shareholders. Conversion of the $3,000,000 note still needs a shareholder vote, which is the next event that can dilute holders. This lands on top of a previously disclosed second Nasdaq deficiency notice for the late Q2 2026 10-Q, so the compliance record is already strained.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BRLS was trading at $1.17 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $24.7M. The 52-week trading range was $0.60 to $3.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.